J&J Speaks Out as Florida Plans to Use an Old Drug in a Lethal Injection Execution @JNJCares | Pharmaguy's Insights Into Drug Industry News | Scoop.it

J&J no longer manufactures etomidate, although it discovered the drug back in the 1960s, but an untried three-drug concoction including the anaesthetic is set to be used in the execution of Mark Asay tomorrow.

 

Now off-patent, several generic drugmakers manufacture the drug and J&J seems unable to intervene directly to stop its use on death row.

 

J&J’s pharmaceutical division, Janssen, said in a statement: “We do not condone the use of our medicines in lethal injections for capital punishment.”

 

“Janssen discovers and develops medical innovations to save and enhance lives. We do not support the use of our medicines for indications that have not been approved by regulatory authorities.”

 

Maya Foa, director of Reprieve, the international rights organisation, said: “The world’s largest drug manufacturer has added its voice to the industry-wide consensus that opposes the misuse of medical products in lethal injection executions.”

 

“Pharmaceutical companies are clear that their drugs are for saving the lives of patients, not ending the lives of prisoners. In Florida particularly, Governor Scott should listen to clear and unequivocal statements from Johnson & Johnson and others calling time on this dangerous misuse of medicines, and stay the execution of Mark Asay on Thursday”